Trial intelligence / Profile preview

Extraneal for hypertriglyceridemia in peritoneal dialysis patients

NCT00397358Phase 4Withdrawn

Sponsor
Vanttive
Start
Nov 2006
Primary completion
Jun 2007
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of icodextrin in hypertriglyceridemia, sponsored by Vanttive. Planned start Nov 2006; status: withdrawn.

02

Drugs

icodextrin
03

Conditions

hypertriglyceridemia

Beyond the preview

Go deeper on NCT00397358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00397358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call